• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION H/S CUVETTE 1/4X1/4-JAPAN; BLOOD GAS MONITOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION H/S CUVETTE 1/4X1/4-JAPAN; BLOOD GAS MONITOR Back to Search Results
Model Number CV-6914
Device Problem Leak/Splash (1354)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/16/2022
Event Type  Injury  
Event Description
The user facility reported to terumo cardiovascular during pre- cardiopulmonary bypass, blood leakage was observed form the cuvette connected to a cardiopulmonary circuit (open heart surgery).There was an unknown amount of blood loss and is considered as serious injury on a pediatric case.Terumo continues to attempt to gain more information regarding this event from the user facility.*there was no delay, the product was changed out, and the procedure was completed successfully with no patient effect.
 
Manufacturer Narrative
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.For this reason, terumo references evaluation conclusion code 11.Component code: 4765 - cuvette health effect ¿ impact code: (b)(6) - serious injury/ illness/ impairment health effect ¿ clinical code:(b)(6)- no clinical signs, symptoms or conditions medical device problem code: 1354- leak/splash investigation findings: 3233 - results pending completion of investigation investigation conclusions: 11 - conclusion not yet available.
 
Event Description
Leakage.
 
Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on may 24, 2023.Upon further investigation of the reported event, the following information is new and/or changed: d9 (device availability - added date returned to manufacturer).G3 (date received by manufacturer).G6 (indication that this is a follow-up report).H2 (follow-up due to additional information).H3 (device evaluation anticipated by manufacturer - a second follow-up will be submitted upon completion of the investigation and/or submission of new information, thus tcvs references conclusions code 11.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations.Upon further investigation of the reported event, the following information is new and/or changed: d4 (additional device information - added exp date).G3 (date received by manufacturer).G6 (indication that this is a follow-up report).H2 (follow-up due to additional information and device evaluation).H3 (device evaluated by manufacturer).H4 (device manufacture date).H6 (identification of evaluation codes 10, 11, 3331, 4210, 25).Type of investigation #1: 10 - testing of actual/suspected device.Type of investigation #2: 11 - testing of device from same lot/batch retained by manufacturer.Type of investigation #3: 3331 - analysis of production records.Investigation findings: 4210 - leakage/seal.Investigation conclusions: 25 ¿ cause traced to manufacturing.The affected sample was visually inspected upon receipt with no anomalies noted.It was then pressurized to 15.0 psi +/- 1, with air and submerged in a water bath for 30 seconds, and a leak was noted immediately near the loop portion of the unit.A retention sample from the same product code and lot number was previously evaluated using the same test method; no visual damage and no leak when pressurized with air and submerged in a water bath was observed.H/s cuvettes are 100% leak tested and visually inspected in process to ensure each part meets tcvs specifications.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Event Description
Leakage.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
H/S CUVETTE 1/4X1/4-JAPAN
Type of Device
BLOOD GAS MONITOR
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
125 blue ball road
elkton MD 21921
Manufacturer (Section G)
SAME
Manufacturer Contact
douglas patton
125 blue ball road
elkton, MD 21921
7346634145
MDR Report Key16996667
MDR Text Key315906745
Report Number1124841-2023-00128
Device Sequence Number1
Product Code DRY
UDI-Device Identifier00699753270138
UDI-Public(01)00699753270138
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K915265
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 06/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/24/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2023
Device Model NumberCV-6914
Device Catalogue NumberN/A
Device Lot NumberYN30
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received06/22/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/10/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-